Fangjun Yu

838 total citations
28 papers, 666 citations indexed

About

Fangjun Yu is a scholar working on Molecular Biology, Endocrine and Autonomic Systems and Physiology. According to data from OpenAlex, Fangjun Yu has authored 28 papers receiving a total of 666 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 11 papers in Endocrine and Autonomic Systems and 6 papers in Physiology. Recurrent topics in Fangjun Yu's work include Circadian rhythm and melatonin (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Fangjun Yu is often cited by papers focused on Circadian rhythm and melatonin (10 papers), Drug Transport and Resistance Mechanisms (4 papers) and Pharmacogenetics and Drug Metabolism (4 papers). Fangjun Yu collaborates with scholars based in China, Japan and Singapore. Fangjun Yu's co-authors include Baojian Wu, Lianxia Guo, Tianpeng Zhang, Cui Zhou, Min Chen, Min Chen, Fei Wang, Shuai Wang, Mengjing Zhao and Xun Chen and has published in prestigious journals such as Nature Communications, Hepatology and British Journal of Pharmacology.

In The Last Decade

Fangjun Yu

27 papers receiving 663 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fangjun Yu China 13 312 197 191 123 63 28 666
Lianxia Guo China 17 450 1.4× 298 1.5× 346 1.8× 150 1.2× 99 1.6× 35 1.0k
Hayato Yanagihara Japan 11 405 1.3× 436 2.2× 179 0.9× 62 0.5× 55 0.9× 14 787
Nityanand Bolshette India 12 119 0.4× 205 1.0× 153 0.8× 46 0.4× 19 0.3× 15 548
Robert P. Curtain Australia 12 171 0.5× 77 0.4× 278 1.5× 141 1.1× 40 0.6× 18 820
Yasushi Okuno Japan 12 199 0.6× 133 0.7× 439 2.3× 23 0.2× 56 0.9× 16 972
Dhiraj G. Kabra Germany 15 173 0.6× 241 1.2× 305 1.6× 24 0.2× 47 0.7× 21 849
Cui Zhou China 12 130 0.4× 81 0.4× 132 0.7× 45 0.4× 33 0.5× 22 361
Kouichirou Wada Japan 18 99 0.3× 395 2.0× 314 1.6× 32 0.3× 43 0.7× 33 999
Andrés Felipe Aristizábal-Pachón Colombia 14 67 0.2× 94 0.5× 247 1.3× 36 0.3× 35 0.6× 41 529
Jens Teichert Germany 16 48 0.2× 132 0.7× 265 1.4× 44 0.4× 71 1.1× 22 823

Countries citing papers authored by Fangjun Yu

Since Specialization
Citations

This map shows the geographic impact of Fangjun Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fangjun Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fangjun Yu more than expected).

Fields of papers citing papers by Fangjun Yu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fangjun Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fangjun Yu. The network helps show where Fangjun Yu may publish in the future.

Co-authorship network of co-authors of Fangjun Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Fangjun Yu. A scholar is included among the top collaborators of Fangjun Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fangjun Yu. Fangjun Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cao, Kerun, Zhengxin Chen, Kun Wang, et al.. (2025). Jieyu I formula and its primary component quercetin alleviate anxiety by modulating neuroregeneration and inflammation via the calcium signaling pathway. Journal of Ethnopharmacology. 356. 120820–120820. 1 indexed citations
2.
Liu, Yuanyuan, Yang Yu, Yan Wu, et al.. (2025). Dysregulation of CRY1 impairs brain thyroid hormone pathway and promotes anxiety-like behavior in male mice. Metabolism. 169. 156292–156292.
3.
Wang, Qidong, Fangjun Yu, Shaoyong Zhang, et al.. (2024). Cellulose acetate-decorated and siloxane-modified hydrophobic melamine foam with excellent selectivity and durability for efficient oil/water separation. Materials Today Sustainability. 28. 101025–101025. 2 indexed citations
4.
Wang, Qidong, Jiayi Zhu, Fangjun Yu, et al.. (2023). A thermoplastic polyurethane-based composite aerogel with low shrinkage and high specific surface area enhanced by activated carbon for highly efficient oil/water separation. Journal of environmental chemical engineering. 11(5). 111077–111077. 8 indexed citations
5.
Ma, Luyao, et al.. (2023). Role of circadian clock in the chronoefficacy and chronotoxicity of clopidogrel. British Journal of Pharmacology. 180(23). 2973–2988. 3 indexed citations
6.
Wang, Jinyi, et al.. (2023). CRY1/2 regulate rhythmic CYP2A5 in mouse liver through repression of E4BP4. Biochemical Pharmacology. 217. 115843–115843. 5 indexed citations
7.
Yu, Fangjun, et al.. (2023). Si-Ni-San reverses dietary fat absorption defects in a murine model of depression. Biomedicine & Pharmacotherapy. 168. 115677–115677. 4 indexed citations
8.
Zhu, Xinyu, Shurong Dong, Fangjun Yu, et al.. (2022). Silicon-Controlled Rectifier Embedded Diode for 7 nm FinFET Process Electrostatic Discharge Protection. Nanomaterials. 12(10). 1743–1743. 3 indexed citations
9.
Yu, Fangjun, et al.. (2022). Recent advances in circadian-regulated pharmacokinetics and its implications for chronotherapy. Biochemical Pharmacology. 203. 115185–115185. 11 indexed citations
10.
Yu, Fangjun, Zhigang Wang, Tianpeng Zhang, et al.. (2021). Deficiency of intestinal Bmal1 prevents obesity induced by high-fat feeding. Nature Communications. 12(1). 5323–5323. 66 indexed citations
11.
Zhang, Tianpeng, Fangjun Yu, Min Chen, et al.. (2021). Dysregulation of REV-ERBα impairs GABAergic function and promotes epileptic seizures in preclinical models. Nature Communications. 12(1). 1216–1216. 45 indexed citations
12.
Chen, Min, et al.. (2020). Circadian Clock Component Rev-erbα Regulates Diurnal Rhythm of UDP-Glucuronosyltransferase 1a9 and Drug Glucuronidation in Mice. Drug Metabolism and Disposition. 48(8). 681–689. 12 indexed citations
13.
Yu, Fangjun, Tianpeng Zhang, Cui Zhou, et al.. (2019). The Circadian Clock Gene Bmal1 Controls Intestinal Exporter MRP2 and Drug Disposition. Theranostics. 9(10). 2754–2767. 65 indexed citations
14.
Chen, Min, Lianxia Guo, Dong Dong, et al.. (2019). The nuclear receptor Shp regulates morphine withdrawal syndrome via modulation of Ugt2b expression in mice. Biochemical Pharmacology. 161. 163–172. 5 indexed citations
15.
Zhang, Tianpeng, Lianxia Guo, Fangjun Yu, Min Chen, & Baojian Wu. (2019). The nuclear receptor Rev-erbα participates in circadian regulation of Ugt2b enzymes in mice. Biochemical Pharmacology. 161. 89–97. 20 indexed citations
16.
Guo, Lianxia, Fangjun Yu, Tianpeng Zhang, & Baojian Wu. (2018). The Clock Protein Bmal1 Regulates Circadian Expression and Activity of Sulfotransferase 1a1 in Mice. Drug Metabolism and Disposition. 46(10). 1403–1410. 38 indexed citations
17.
Zhao, Mengjing, Tianpeng Zhang, Fangjun Yu, Lianxia Guo, & Baojian Wu. (2018). E4bp4 regulates carboxylesterase 2 enzymes through repression of the nuclear receptor Rev-erbα in mice. Biochemical Pharmacology. 152. 293–301. 37 indexed citations
18.
Yu, Fangjun, Tianpeng Zhang, Lianxia Guo, & Baojian Wu. (2018). Liver Receptor Homolog-1 Regulates Organic Anion Transporter 2 and Docetaxel Pharmacokinetics. Drug Metabolism and Disposition. 46(7). 980–988. 9 indexed citations
20.
Zhang, Tianpeng, Mengjing Zhao, Danyi Lu, et al.. (2017). REV-ERBα Regulates CYP7A1 Through Repression of Liver Receptor Homolog-1. Drug Metabolism and Disposition. 46(3). 248–258. 55 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026